Home » Topics » BioWorld Science

BioWorld Science
RSS

Modus collaborates with Imperial College London on clinical study of sevuparin in malaria

June 18, 2021

Akaal reports preclinical data on AK-119 in neuropathic pain

June 18, 2021

Algernon plans phase I study of AP-188 for stroke

June 18, 2021

FDA accepts IND for phase I trial of Xilio's XTX-101 in solid tumors

June 18, 2021

BriaCell advances personalized immunotherapies for prostate cancer, melanoma and lung cancer

June 18, 2021

Phase II results presented for ZYN-002 in children and adolescents with DEE

June 18, 2021

PureTech advances its wholly owned pipeline

June 18, 2021

Biogen discontinues gosuranemab based on phase II data in Alzheimer's disease

June 17, 2021

Loss of RKIP tied to aggressiveness in HNSCC

June 17, 2021

Early phase I data presented for LVGN-6051 as monotherapy and in combination with pembrolizumab

June 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...